Pooled post hoc analysis of 489 patients with locally advanced rectal cancer from GRECCAR4 and PRODIGE23: adjuvant chemotherapy was associated with better 3-year DFS in ypN+ patients after chemoradiotherapy, but not after FOLFIRINOX-based TNT or in ypN0/cN+ patients.
Secondary analysisn = 489
Denost et al. Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23